Acadian Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.45M | Buy |
2,433,850
+238,659
| +11% | +$339K | 0.01% | 681 |
|
|
2025
Q1 | $3.36M | Buy |
2,195,191
+451,044
| +26% | +$689K | 0.01% | 614 |
|
|
2024
Q4 | $4.32M | Sell |
1,744,147
-334,140
| -16% | -$828K | 0.01% | 560 |
|
|
2024
Q3 | $2.39M | Buy |
2,078,287
+164,838
| +9% | +$189K | 0.01% | 694 |
|
|
2024
Q2 | $2.1M | Sell |
1,913,449
-221,918
| -10% | -$244K | 0.01% | 746 |
|
|
2024
Q1 | $2.65M | Sell |
2,135,367
-216,040
| -9% | -$268K | 0.01% | 597 |
|
|
2023
Q4 | $2.47M | Buy |
+2,351,407
| New | +$2.47M | 0.01% | 620 |
|
|
2021
Q1 | – | Sell |
-85,362
| Closed | -$551K | – | 2034 |
|
|
2020
Q4 | $551K | Sell |
85,362
-108,834
| -56% | -$703K | ﹤0.01% | 1204 |
|
|
2020
Q3 | $499K | Buy |
194,196
+99,363
| +105% | +$255K | ﹤0.01% | 1126 |
|
|
2020
Q2 | $153K | Buy |
94,833
+76,683
| +422% | +$124K | ﹤0.01% | 1583 |
|
|
2020
Q1 | $19K | Buy |
+18,150
| New | +$19K | ﹤0.01% | 1651 |
|
|
2019
Q4 | – | Sell |
-238,234
| Closed | -$257K | – | 1820 |
|
|
2019
Q3 | $257K | Buy |
+238,234
| New | +$257K | ﹤0.01% | 1254 |
|